| Literature DB >> 28794464 |
Maryam B Khadzhieva1,2, Dmitry S Kolobkov1, Svetlana V Kamoeva3, Lyubov E Salnikova4,5.
Abstract
Pelvic organ prolapse (POP) is a highly disabling condition common for a vast number of women worldwide. To contribute to existing knowledge in POP pathogenesis, we performed a systematic review of expression studies on both specific gene and whole-genome/proteome levels and an in silico analysis of publicly available datasets related to POP development. The most extensively investigated genes in individual studies were related to extracellular matrix (ECM) organization. Three premenopausal and two postmenopausal sets from two Gene Expression Omnibus (GEO) studies (GSE53868 and GSE12852) were analyzed; Gene Ontology (GO) terms related to tissue repair (locomotion, biological adhesion, immune processes and other) were enriched in all five datasets. Co-expression was higher in cases than in controls in three premenopausal sets. The shared between two or more datasets up-regulated genes were enriched with those related to inflammatory bowel disease (IBD) in the NHGRI GWAS Catalog. ECM-related genes were not over-represented among differently expressed genes. Up-regulation of genes related to tissue renewal probably reflects compensatory mechanisms aimed at repair of damaged tissue. Inefficiency of this process may have different origins including age-related deregulation of gene expression.Entities:
Mesh:
Year: 2017 PMID: 28794464 PMCID: PMC5550478 DOI: 10.1038/s41598-017-08185-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Summary of literature data on POP-related expression changes for selected genes. Numbers in boxes indicate the number of studies (Fig. 1a) and subjects (Fig. 1b) for each marker. Letter symbols (a–g) in the small boxes are decrypted in the right upper corner.
Figure 2(a) Heat map for GO terms cluster representatives for genes considered in POP studies. (b) GO terms associated with the selected genes. Color indicates the user-supplied P- value; the term ‘frequency’ means frequency of the specific term in the underlying GO annotation database.
Characteristics of the whole genome/proteome studies of POP.
| Dataset | Number of samples (age/MP status) | Analysis | DEG (DEP) | Main findingsa | Confirmation of whole genome/proteome data | Reference |
|---|---|---|---|---|---|---|
| Pubococcygeus muscle in Caucasian POP patients and mixed ethnicity controls | 5 cases (58.9 ± 5.5); 5 controls (45.5 ± 11.4) | Microarray gene expression | Down-regulation in POP patients: FC > 2.0, 257 genes; FC > 5, 20 genes; FC > 10, 3 genes. Up-regulation in POP patients: FC > 2.0, 479 genes; FC > 5, 18 genes; FC > 10, 2 genes. | The genes | No |
|
| Full-thickness vaginal wall biopsies from patients with POP and age-, parity -, and body mass index -matched controlsb | 5 PrM cases, 5 PrM controls | Microarray gene expression | Upregulated genes (n = 50) comprised those involved in smooth muscle contraction, proteolysis, response to oxidative stress, transcriptional regulation, cytoskeletal organization, and lipid catabolism. | The | mRNA analysis for 4 matched pairs of POP/control tissues |
|
| USLs and RLs from mixed ethnicity patients with uterine prolapse (POP-Q stage ≥ 2) and controls | 8 POP patients (5 PrM and 3 PM); 9 controls (6 PrM and 3 PM) | Microarray gene expression | In a combined analysis of expression changes in USLs and RLs, 1521 genes were up-regulated and 1193 genes were down-regulated with FC change 1.5. 249 up-regulated gene probes met FDR criteria ≤ 5.18. | After FDR correction for multiple testing, genes enriched for ‘immunity and defense’ were up-regulated in POP patients. | qRT-PCR Up-regulation in POP patients: |
|
| Pubocervical fascia from females with POP and SUI and from asymptomatic controlsb | 4 cases (PM); 3 controls (PM) | Proteomic analysis (two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry) | 7 proteins with an expression FC more than two (3.8 ─ 54.3-fold). | The expression levels of transgelin (FC 54.3), smooth muscle gamma-actin (FC 6.3), myosin light polypeptide 6 (FC 4.4), and alpha-1 antitrypsin precursor (FC 4.3) were higher in patients than in controls. | 2-DE western blot analysis for transgelin |
|
| USLs from Asian women with POP-Q stage 3-4 (cases) or 0-1 (controls) | 12 cases (PM), 5 controls (PM) | Microarray gene expression | 143 genes were up-regulated and 87 genes were down-regulated with FC > 1.5 ( | The expression levels of | qRT-PCR for the genes |
|
| USLs from patients with uterine prolapse and controlsb | 16 POP patients (15 patients PM); 9 controls (7 females PM) | Microarray gene expression | 21 up-regulated and 7 down-regulated genes with FC > 2.0 were found in patients with POP compared to the control group. | Down-regulation in POP patients compared with controls after FDR correction for multiple testing: | No |
|
| USL samples of patients with stage II to stage IV POP (mean age 61 years) and normal controls (mean age 55 years)b | No data | RNA-seq (a HiSeqTM 2500 platform (Illumina)) | After FDR-correction, a total of 81 genes had different expression patterns in POP patients and controls. Sixty-six DEGs did not differ between the POP samples with different stages | Canonical Wnt receptor signaling pathway was the most significantly enriched GO term ( | No |
|
aData are uncorrected for multiplicity, otherwise specified. bEthnicity is not specified.
Abbreviations: DEG, differently expressed genes; DEP, differently expressed proteins; FC, fold change; FDR, false discovery rate; PM, postmenopausal; PrM, premenopausal; RLs, round ligaments; SUI, stress urinary incontinence; USLs, uterosacral ligaments.
Characteristics of the POP datasets in the Gene Expression Omnibus (GEO) database repository.
| Dataset | Reference | Tissue | Number of samples | GEO accession no; Platform | Number of DEGa with FDR-corrected | Number of DEGa with FC ≥ 2.0 and |
|---|---|---|---|---|---|---|
| PrM Caucasian women (cystocele POP-Q stage ≥ 2), n = 12 | Citation missing | AVW (POP site) versus precervical AVW (non POP site) | 12 women (24 samples) | GSE53868; GPL18142 Agilent-014850 WHGM 4 × 44K G4112F | 50 (↑ 31; ↓ 19) | 74 (↑ 58; ↓16) |
| PrM POP women, n = 5b | Brizzolara | RLs | 5 | GSE12852; GPL2986 ABI Human Genome Survey Microarray Version 2 | PrM_RLs set 0 | PrM_RLs set 287 (↑ 246; ↓ 41) |
| USLs | 5 | |||||
| PrM controls, n = 6b | RLs | 6 | PrM_USLs set 0 | PrM_USLs set 972 (↑ 949; ↓23) | ||
| USL | 6 | |||||
| PM POP women, n = 3b | RL | 3 | PM_RLs set 0 | PM_RLs set 485 (↑ 345; ↓ 140) | ||
| USL | 3 | |||||
| PM controls, n = 3b | RL | 3 | PM_USLs set 2 (↑ 2; ↓ 0) | PM_USLs set 494(↑ 263; ↓ 231) | ||
| USL | 3 |
a↑ up-regulation; ↓ down-regulation; bMixed ethnicity.
Abbreviations: AVW, anterior vaginal wall; DEG, differently expressed genes; FC, fold change; FDR, false discovery rate; WHGM, whole human genome microarray; PM, postmenopausal; PrM, premenopausal; RLs, round ligaments; USLs, uterosacral ligaments.
Figure 3Graph for the results of enrichment analysis for five gene sets up-regulated in POP. More similar nodes are placed closer together. The line width indicates the degree of similarity between GO terms cluster representatives. Clustering by color into super clusters was obtained by using REVIGO TreeMap application.
Figure 4Co-expression heatmaps and density plots. Heatmaps display Pearson correlation coefficients for gene expression in controls (above the diagonal) and cases (below the diagonal). Density plots present correlation coefficients distribution for controls (blue) and cases (red) with addition of percentage of Pearson correlations (r-values) ≥ 0.7 and ≤ -0.7. Density plots x-axis: Pearson correlation coefficient (r), y-axis: density.
Figure 5REVIGO scatterplot for GO terms cluster representatives for shared genes up-regulated in POP tissues. Bubble color indicates the user-supplied P - value; size shows the frequency of the GO term in the GO annotation database.
The results of gene set enrichment analysis for shared genes up-regulated in POP tissues.
| Term | Input number | Background number |
| Corrected | Genes |
|---|---|---|---|---|---|
|
| |||||
| Malaria (hsa05144) | 7 | 49 | 1,25E-09 | 1,93E-07 |
|
| Influenza A (hsa05164) | 8 | 176 | 3,48E-07 | 2,69E-05 |
|
| Rheumatoid arthritis (hsa05323) | 5 | 91 | 2,51E-05 | 1,19E-03 |
|
| PI3K-Akt signaling pathway (hsa04151) | 8 | 342 | 3,91E-05 | 1,19E-03 |
|
| AGE-RAGE signaling pathway in diabetic complications (hsa04933) | 5 | 101 | 4,04E-05 | 1,19E-03 |
|
| Chagas disease (American trypanosomiasis) | 5 | 104 | 4,62E-05 | 1,19E-03 |
|
| Hepatitis C (hsa05142) | 5 | 133 | 1,41E-04 | 2,43E-03 |
|
| Hepatitis B (hsa05161) | 5 | 146 | 2,15E-04 | 3,32E-03 |
|
| Phagosome (hsa04145) | 5 | 155 | 2,80E-04 | 3,95E-03 |
|
| HTLV-I infection (hsa05166) | 6 | 259 | 3,90E-04 | 4,91E-03 |
|
| Transcriptional misregulation in cancer (hsa05202) | 5 | 180 | 5,44E-04 | 5,63E-03 |
|
| Herpes simplex infection (hsa05168) | 5 | 186 | 6,29E-04 | 6,09E-03 |
|
| Cytokine-cytokine receptor interaction (hsa04060) | 5 | 265 | 2,89E-03 | 2,03E-02 |
|
| Pathways in cancer (hsa05200) | 6 | 397 | 3,31E-03 | 2,13E-02 |
|
|
| |||||
| Inflammatory bowel disease | 9 | 271 | 8,03E-07 | 1,26E-04 |
|
| Crohn’s disease | 6 | 256 | 3,68E-04 | 1,15E-02 |
|